Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b
about
Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparinTissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.Extra-renal manifestations of complement-mediated thrombotic microangiopathies.Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Complement control protein factor H: the good, the bad, and the inadequate.Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosusCardiopulmonary bypass technology transfer: musings of a cardiac surgeon.Altering the course of proliferative nephritides: the challenge of the 1990s.Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophagesPorin polypeptide contributes to surface charge of gonococciDeposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.Currently available biomaterials for use in cardiopulmonary bypass.Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.Discrimination between host and pathogens by the complement system.Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.Complement activation during hemodialysis.Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After AdministrationMast cells: accessory cells which potentiate fibrosis.Inhibition of zymosan-induced alternative complement pathway activation by concanavalin A.Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuriaReduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides.Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.Resistance of the Echinococcus granulosus cyst wall to complement activation: analysis of the role of InsP6 deposits.The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.
P2860
Q28141946-D49946EA-FCC9-47C3-91CD-534F2319CBC0Q33405609-78A66FDA-2CB3-411E-B01C-0EEE5419471CQ33417814-BFF6377B-9865-40F6-A086-D4535C224153Q33596128-2B83E79D-F68F-4ADD-9B40-87A76B4D29DDQ34067107-159B3C47-DCC1-4559-8B66-7EC471464EFAQ34144798-F30FD986-99F2-419F-A45C-576C314B8734Q34629373-2B080689-2679-4695-868D-007EAE263139Q34771783-B6689DA2-AF03-4C12-8E68-073806E1848AQ35154105-0771DA64-6282-4B8F-9640-E8D961DCEE68Q35313833-289EEC07-154E-499F-96AD-48C88B8ACA0CQ35623872-9541D5CF-478C-4482-BF16-3BFAAFC938FEQ36350126-7CDBA22D-E5A9-4977-B52F-525FC878CAAAQ36426487-9463A742-3CD7-4577-ADAF-7D81F3D2C629Q36471548-B0E07458-DC74-407D-9652-C16F890AF490Q37026070-88E03DDF-DBA9-4A71-8BE3-30BF14B5C247Q37170042-27606DBA-9A10-4215-8968-A792B6A4E3CBQ38596477-8F7FE31C-AE55-447E-BA99-6CCDFF8AE2EFQ38698334-81E7DE7C-3BD2-4C58-BC01-E5892B379781Q38864097-0C1835DF-C7FE-412D-81BA-19864B74DD9BQ38949784-E2936111-51A8-46FE-A593-F2E2228220CFQ39633236-D81EFD11-4B72-4B15-B42E-A27CF24AF722Q40403511-C81BAE08-A588-4457-ABCE-6449309DF6F2Q40599517-C346BA56-EE5A-4CA1-BC7D-0D493AE41E96Q40684721-1672C1AB-EA22-4A42-9C28-3672EF3C7A77Q40862339-8923CFFA-5054-42A0-B0D7-9F7566E9D782Q42115809-1E9FBF22-18EA-4E01-8912-52F7A4C3FAAAQ42792554-F81352CB-B316-4CAC-926D-21964BC12794Q46620580-E35CD9F7-5B3E-4A73-9E25-2A2FC63D3D98Q49721910-18AB98A3-5999-4779-98DC-4DCEB246AA0AQ55252352-19FD564A-82F9-4F90-8ABE-78EBA8D6CDF3
P2860
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Surface-associated heparin inh ...... proteins on particle-bound C3b
@ast
Surface-associated heparin inh ...... proteins on particle-bound C3b
@en
type
label
Surface-associated heparin inh ...... proteins on particle-bound C3b
@ast
Surface-associated heparin inh ...... proteins on particle-bound C3b
@en
prefLabel
Surface-associated heparin inh ...... proteins on particle-bound C3b
@ast
Surface-associated heparin inh ...... proteins on particle-bound C3b
@en
P2093
P2860
P356
P1476
Surface-associated heparin inh ...... proteins on particle-bound C3b
@en
P2093
Kazatchkine MD
Silbert JE
P2860
P304
P356
10.1084/JEM.150.5.1202
P407
P577
1979-11-01T00:00:00Z